Survivors at risk: Hodgkin lymphoma survivors at high risk of second cancers.
No Thumbnail Available
Embargo End Date
ICR Authors
Authors
Sud, A
Document Type
Journal Article
Date
2017-06-01
Date Accepted
2017-03-30
Abstract
Amit Sud speaks to Sebastian Dennis-Beron, Commissioning Editor: Amit Sud is a clinical research fellow in Hematology at the Institute of Cancer Research, UK. He undertook his undergraduate medical training at the University of Manchester, gaining an honors degree. He completed his Masters in Medical Research at Manchester University, gaining a distinction. He continued his medical training in Manchester and London and started his specialization in Hematology in South West London. He was successful in obtaining a Cancer Research UK funded clinical research fellowship in Hematology under the supervision of Professor Richard Houlston at the Institute of Cancer Research. His current research focus is that of genetic susceptibility to Hodgkin lymphoma. He is a trainee member of the NCRI Lymphoma Clinical Studies Group.
Citation
International journal of hematologic oncology, 2017, 6 (1), pp. 5 - 8
Source Title
Publisher
Informa UK Limited
ISSN
2045-1393
eISSN
2045-1407
Collections
Research Team
Cancer Genomics